… Polyethylene glycol 3350 is not metabolized by bowel … safety and efficacy of Braintree PEG
laxative (Miralax) for the short term treatment of constipation, but long term safety and efficacy …

Aim : To compare standard and maximum daily doses of polyethylene glycol 3350 plus
electrolytes (Transipeg) and polyethylene glycol 4000 (Forlax) in a multicentre, double‐blind, …

… a 17- or 34-g daily dose of polyethylene glycol (PEG) 3350 (MiraLax) is safe and effective
for the treatment of constipation, with the best efficacy seen in wk 2 of treatment. The purpose …

… efficacy and safety of polyethylene glycol for the long-term treatment of constipation in
children. Because of excellent patient acceptance, polyethylene glycol … , efficacy, safety, patient …

… by attaching branched polyethylene glycol (PEG). … safety and tolerance, in T2D patients,
after 12 weeks of treatment. The objective of this study was to evaluate the efficacy and safety of …

… L polyethylene glycol (PEG)-based bowel preparation agent NER1006 (Plenvu; Norgine,
Harefield, UK) has shown high cleansing efficacy … to evaluate the efficacy and safety of 1L PEG-…

… laxatives used to manage constipation include polyethylene glycol (PEG) 3350 and lactulose…
Its efficacy and safety have been established in multiple clinical trials involving children and …

AIMS To assess the long term therapeutic effectiveness, safety, and tolerability of low daily
doses of isosmotic PEG electrolyte solutions (PMF-100) administered for a six month period …

… Recently polyethylene glycol has been introduced as an effective and safe drug to treat …
The purpose of this study was to evaluate clinical efficacy and safety of PEG 3350 solution …

… of PEGs could jeopardize the efficacy and safety of PEGylated products [102,103]. Over
the past few decades PEG has generally been recognized as safe and as such is commonly …